- Health A to Z
Healthline Premium Tools
Advertisement
Marketplace
|
... also an essential genetic tool used to understand and develop treatments for medical conditions ranging from Huntington's disease and Alzheimer's disease to aging and diabetes. "A lot of things we now call breakthroughs were once considered pretty ...
|
|
... Dr. Anne Schuchat. the Director of the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention announced that Friday's FluView report which will reveal ' substantial flu illness in most of the ...
|
|
... hours. She currently serves as an advisory director of the McBride Foundation and is a director of Allied Arts, Huntington's Disease Association, Traveler's Aid, Prevent Blindness Oklahoma, Central Oklahoma Turning Point Tobacco Use Prevention ...
|
|
... diseases suffer from cognitive deficits, abnormal mood states, and difficult behaviors that are fundamental to their disease states or reaction to the illness, and psychiatrists are increasingly asked to help manage such patients. This book from the ...
|
|
... would be unlawful. About Amarin Amarin is a late-stage biopharmaceutical company with a focus on cardiovascular disease. The Company's lead product candidate is AMR101, a prescription grade Omega-3 fatty acid comprising not less than 96% ultra-pure ...
|
|
... treat conditions such as Type 1 diabetes, neuronal degenerative disorders such as Alzheimer's, Parkinson's and Huntington's disease, cardiovascular disease, paralysis due to spinal cord injury, liver disease, stroke, heart attack, joint bone repair ...
|
|
Inhibiting the protein Hsp70 rapidly reduces brain levels of tau, a protein associated with Alzheimer's disease when it builds up abnormally inside nerve cells affecting memory, neuroscientists at the University of South Florida found.
|
|
... e clinical testing. Raptor seeks treatments for nephropathic cystinosis, non-alcoholic steatohepatitis or NASH, Huntington's Disease and aldehyde dehydrogenase deficiency.
|
|
... ; Psychology / Psychiatry Article Date: 30 Sep 2009 - 1:00 PDT Dr. Roger Rosenberg, director of the Alzheimer's Disease Center at UT Southwestern Medical Center, has been awarded the first Medal for Scientific Achievement by the World Federation of ...
|
|
If you are a caregiver for someone with Alzheimer's disease or another disabling brain disorder, there is a place for you to find support.
|
|
... and Huntington Memorial in Pasadena, are taking typical flu season precautions. "We are monitoring the (Centers for Disease Control and Prevention) guidelines every day," said Huntington Memorial spokeswoman Andrea Stradling. "We are evaluating ...
|
|
... clinical testing. Raptor seeks treatments for nephropathic cystinosis, non-alcoholic steatohepatitis or NASH, Huntington's Disease and aldehyde dehydrogenase deficiency. After the deal goes through, TorreyPines will take on the Raptor name and ...
|
|
... ng, treating and managing disorders of the brain and nervous system such as epilepsy, dystonia, migraine, Huntington's disease, and dementia. For more information about the American Academy of Neurology, visit www.aan.com or www.thebrainmatters.org .
|
|
Main Category: Neurology / Neuroscience Also Included In: Clinical Trials / Drug Trials ; Huntingtons Disease ; Heart Disease Article Date: 28 Sep 2009 - 2:00 PDT printer friendly view / write opinions rate article Using clever chemistry, a Scripps Research team has pinpointed the enzyme target of a drug group that stops the progression of the ...
|
|
... in the population prevalence of cardiovascular risk factors.2 They estimated that the decline in coronary heart disease mortality between 1980 and 2000 resulting from reductions in risk factors was 24% for total cholesterol, 20% for systolic blood ...
|
|
... These foods have more than just taste to offer. Their nutrients may reduce the risk of cancers, coronary heart disease and hypertension. Pumpkin nutrition The bright orange color of pumpkin and squash is a dead giveaway that they're loaded with an ...
|
|
Discovery takes researchers 1 step closer to human clinical trials and could improve understanding of other diseases Using clever chemistry, a Scripps Research team has pinpointed the enzyme target of a drug group that stops the progression of the devastating disease Friedreich's ataxia in mice and may do the same for humans.
|
|
... nervous system . In August, the company bought a drug intended to treat muscle movements caused by Parkinson's disease drugs, for example. Schott said the developing Huntington's disease drug Xenazine is a "solid start" to the company's strategy, ...
|
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2009 Healthline Networks, Inc. All rights reserved.